Antiangiogenic therapy for breast cancer

Pablo M. Bedano, Bryan Schneider, Kathy Miller, George W. Sledge

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Angiogenesis plays a central role in both local tumor growth as well as distant metastasis in breast cancer (1). The inhibition of angiogenesis is an attractive therapeutic target, with the potential for widespread activity and low toxicity, as well as the potential for synergy with classic cytotoxic therapy and radiotherapy. In this chapter, we explore the role of angiogenesis in breast cancer and recent attempts to quantify angiogenesis and tumor vasculature. We also discuss clinical trial results, potential mechanisms of resistance, and the special challenges posed by the development of antiangiogenic agents.

Original languageEnglish (US)
Title of host publicationAntiangiogenic Cancer Therapy
PublisherCRC Press
Pages559-586
Number of pages28
ISBN (Electronic)9781420004298
ISBN (Print)9780849327995
DOIs
StatePublished - Jan 1 2007

Fingerprint

Tumors
Breast Neoplasms
Angiogenesis Inhibitors
Radiotherapy
Toxicity
Neoplasms
Clinical Trials
Neoplasm Metastasis
Therapeutics
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Bedano, P. M., Schneider, B., Miller, K., & Sledge, G. W. (2007). Antiangiogenic therapy for breast cancer. In Antiangiogenic Cancer Therapy (pp. 559-586). CRC Press. https://doi.org/10.1201/9781420004298

Antiangiogenic therapy for breast cancer. / Bedano, Pablo M.; Schneider, Bryan; Miller, Kathy; Sledge, George W.

Antiangiogenic Cancer Therapy. CRC Press, 2007. p. 559-586.

Research output: Chapter in Book/Report/Conference proceedingChapter

Bedano, PM, Schneider, B, Miller, K & Sledge, GW 2007, Antiangiogenic therapy for breast cancer. in Antiangiogenic Cancer Therapy. CRC Press, pp. 559-586. https://doi.org/10.1201/9781420004298
Bedano PM, Schneider B, Miller K, Sledge GW. Antiangiogenic therapy for breast cancer. In Antiangiogenic Cancer Therapy. CRC Press. 2007. p. 559-586 https://doi.org/10.1201/9781420004298
Bedano, Pablo M. ; Schneider, Bryan ; Miller, Kathy ; Sledge, George W. / Antiangiogenic therapy for breast cancer. Antiangiogenic Cancer Therapy. CRC Press, 2007. pp. 559-586
@inbook{998304206e474186ab4f8f1ca37bf2ae,
title = "Antiangiogenic therapy for breast cancer",
abstract = "Angiogenesis plays a central role in both local tumor growth as well as distant metastasis in breast cancer (1). The inhibition of angiogenesis is an attractive therapeutic target, with the potential for widespread activity and low toxicity, as well as the potential for synergy with classic cytotoxic therapy and radiotherapy. In this chapter, we explore the role of angiogenesis in breast cancer and recent attempts to quantify angiogenesis and tumor vasculature. We also discuss clinical trial results, potential mechanisms of resistance, and the special challenges posed by the development of antiangiogenic agents.",
author = "Bedano, {Pablo M.} and Bryan Schneider and Kathy Miller and Sledge, {George W.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1201/9781420004298",
language = "English (US)",
isbn = "9780849327995",
pages = "559--586",
booktitle = "Antiangiogenic Cancer Therapy",
publisher = "CRC Press",

}

TY - CHAP

T1 - Antiangiogenic therapy for breast cancer

AU - Bedano, Pablo M.

AU - Schneider, Bryan

AU - Miller, Kathy

AU - Sledge, George W.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Angiogenesis plays a central role in both local tumor growth as well as distant metastasis in breast cancer (1). The inhibition of angiogenesis is an attractive therapeutic target, with the potential for widespread activity and low toxicity, as well as the potential for synergy with classic cytotoxic therapy and radiotherapy. In this chapter, we explore the role of angiogenesis in breast cancer and recent attempts to quantify angiogenesis and tumor vasculature. We also discuss clinical trial results, potential mechanisms of resistance, and the special challenges posed by the development of antiangiogenic agents.

AB - Angiogenesis plays a central role in both local tumor growth as well as distant metastasis in breast cancer (1). The inhibition of angiogenesis is an attractive therapeutic target, with the potential for widespread activity and low toxicity, as well as the potential for synergy with classic cytotoxic therapy and radiotherapy. In this chapter, we explore the role of angiogenesis in breast cancer and recent attempts to quantify angiogenesis and tumor vasculature. We also discuss clinical trial results, potential mechanisms of resistance, and the special challenges posed by the development of antiangiogenic agents.

UR - http://www.scopus.com/inward/record.url?scp=85055533888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055533888&partnerID=8YFLogxK

U2 - 10.1201/9781420004298

DO - 10.1201/9781420004298

M3 - Chapter

AN - SCOPUS:85055533888

SN - 9780849327995

SP - 559

EP - 586

BT - Antiangiogenic Cancer Therapy

PB - CRC Press

ER -